Status:
COMPLETED
Atrial Fibrillation After PFO Closure
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Stroke
Eligibility:
All Genders
18-60 years
Brief Summary
An increased risk of atrial fibrillation (AF) after patent foramen ovale (PFO) closure was observed in randomized trials but systematic screening of AF was not performed in these studies. Purpose: The...
Detailed Description
This is a prospective, bicentric, observational cohort study which will be performed in University hospital center of Montpellier and Nîmes The study will include all consecutive patients, admitted fo...
Eligibility Criteria
Inclusion
- Men or women over the age of 18 to 60
- Benefiting from the closure of the FOP percutaneously after a cryptogenic ischemic stroke or a TIA (indication validated during a multidisciplinary meeting with neurologists and cardiologists)
Exclusion
- Inability to perform a 24h ECG Holter
- Pregnant or lactating women
- Vulnerable people
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04290052
Start Date
March 1 2020
End Date
January 1 2022
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295